Phase 1 Basal Cell Carcinoma (BCC) Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas

Basal Cell Carcinoma (BCC)

Nathalie Zeitouni20 enrolled1 locationNCT06623201

Completed

Phase 1

A phase I study of the Dz13 drug targeting the c-Jun gene in subjects with skin cance (nodular Basal Cell Carcinoma).

Nodular Basal Cell Carcinoma (BCC)

University of New South Wales9 enrolled1 locationACTRN12610000162011